Skip to main content
Caplight Logo









Waiv

Waiv

Private
ParisHealthcare & Life Scienceshttps://wearewaiv.com/

Last Round

Series A

Apr 24, 2026

Total Funding Raised

$68M

Company Overview

Waiv is a health technology company that provides an AI-powered precision testing platform for oncology.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Biotechnology, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

precision oncologydigital pathologybiomarker discoverymedical AIAI pathologyAI diagnosticspathology AIclinical decision supportcomputational pathologypatient stratificationfoundation modelsmultimodal clinical dataclinical trial supportdiagnostic platformoncology informatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Waiv Comparables

Compare Waiv with similar companies based on industry and business-model similarity.

Waiv comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spotlight Medical
81%
ArteraAI
81%
4D Path
79%

Waiv Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 24, 2026
Early FundingMar 12, 2026

Waiv Investors

Notable investors and investment history

Waiv investors
InvestorRounds
SISTAFUNDSeries A, Early Funding
Serena Data VenturesSeries A, Early Funding
Alpha Intelligence CapitalSeries A, Early Funding
OTB VenturesSeries A, Early Funding
KaristaSeries A, Early Funding
CRB Health TechSeries A

Waiv Filings

Explore SEC and related filing metadata, where available.

Waiv filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Waiv's valuation, stock price, and market status.

Is Waiv a public or private company?

Waiv is a private company.

What is the current stock price of Waiv?

Waiv is a private company with no public stock price. No recent secondary market data is available.

How much is Waiv worth (valuation)?

Valuation information for Waiv is not publicly available.

Can I buy Waiv stock?

Waiv shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Waiv's last funding round?

Waiv's most recent funding round was Early Funding on March 12, 2026.

Who are the main investors in Waiv?

Key investors in Waiv include Alpha Intelligence Capital, OTB Ventures.

Will Waiv IPO soon?

No public IPO plans have been announced for Waiv.

How can I track Waiv secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Waiv's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Year Founded2026
Last FundingApr 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?